
What we do
Our expertise
We calculate the economic efficiency and evaluate the effectiveness of investment in chosen areas of healthcare and emerging technologies. We provide the valuation of the proposed solutions in the context of economic, social, demographic and quality of life (QALY) aspects.
Our strategic assessments provide analysis and critical insights for the development and implementation of effective business decisions. We help realistically assess the financial, technological and social aspects. The multifactorial evaluation determines the technical possibilities and market potential of the innovation with objective analysis, data interpretation and insights.
In regulatory affairs, we perform a gap analysis of our client's regulatory strategy. We set and design the individual steps, including the necessary tests and verifications, which are necessary for a successful medical device conformity assessment process.
HEALTH ECONOMICS
REGULATORY AFFAIRS
news
Stay up to date
News

New colleague on Board in Regulatory Affairs team
We are excited to welcome Petr Straka to our Regulatory Affairs team. Petr brings valuable expertise and a strong background in regulatory processes, making him a great addition to our department. His skills and experience will play a key role in s...
News

Start of the new Horizon Europe project – NAP4DIVE
Betthera s.r.o. joins European consortium of NAP4DIVE which aims to revolutionize drug development for central nervous system (CNS) diseases by creating advanced non-animal models to test and predict nanoparticle-based drug delivery across the human ...
News

Start of the new Horizon Europe project – NEOLIVER
Towards 3D bioprinted liver tissue constructs: NEOLIVER Betthera s.r.o. joins European consortium to develop Automated Generation of Dense, Functional and Perfusable Bioprinted Liver Constructs for Transplantation European Union (EU) Horizon Europe a...
testimonials
Kind words
Do you know the real value for your customers?
Let's talk